Literature DB >> 20826021

Patients with premature cardiovascular disease and a positive family history for cardiovascular disease are prone to recurrent events.

Ties A Mulders1, Zainna Meyer, Christel van der Donk, Abraham A Kroon, Isabel Ferreira, Coen D A Stehouwer, Sara-Joan Pinto-Sietsma.   

Abstract

BACKGROUND: Premature cardiovascular disease (CVD) is treated in the same way as CVD of advanced age. However, in patients with premature CVD and a family history of CVD, different -possibly genetic- mechanisms may underlie this disease, which current medical treatment is not targeted to. This suggests that subjects with a genetic predisposition to CVD are more likely to have recurrent cardiovascular events.
METHODS: We retrospectively investigated 291 patients with premature CVD and assessed the amount of recurrent events according to family history in a follow-up period of 31 years. Premature CVD was defined as an event <51 years for men or <56 for women. We used a Cox proportional hazards model to estimate the relationship between a positive family history and recurrence of cardiovascular events.
RESULTS: Patients with recurrent events had more often a positive family history (60.0% vs. 47.1%; p<0.05), were more often smokers (85.2% vs. 70.7%; p<0.05), had more often hypertension (36.3% vs. 23.6%; p<0.05) and had a longer follow-up period (10.0 years vs. 5.4 years; p<0.001) than patients without recurrent events. After adjusting for these differences and modelling time to events, a positive family history was independently associated with recurrent events (Hazard ratio 1.31 (95% confidence intervals (CI) 1.01-1.72; p<0.05)).
CONCLUSIONS: Patients with a genetic predisposition for CVD are at risk for recurrent events, after adjusting for risk factors and other confounders. This might imply that in subjects with a genetic predisposition for CVD different pathophysiological mechanisms are active, leading to recurrent events.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20826021     DOI: 10.1016/j.ijcard.2010.08.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update.

Authors:  Christopher Labos; George Thanassoulis
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

2.  Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH cohorts.

Authors:  Christopher Labos; Sara C Martinez; Rui Hao Leo Wang; Petra A Lenzini; Louise Pilote; Peter Bogaty; James M Brophy; James C Engert; Sharon Cresci; George Thanassoulis
Journal:  Atherosclerosis       Date:  2015-07-17       Impact factor: 5.162

Review 3.  Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study.

Authors:  Samira Taravatmanesh; Davood Khalili; Soheila Khodakarim; Samaneh Asgari; Farzad Hadaegh; Fereidon Azizi; Siamak Sabour
Journal:  J Tehran Heart Cent       Date:  2017-07

4.  Increased carotid plaque burden in patients with family medical history of premature cardiovascular events in the absence of classical risk factors.

Authors:  Paul W Atkins; Hernán A Perez; J David Spence; Sonia E Muñoz; Luis J Armando; Néstor H García
Journal:  Arch Med Sci       Date:  2019-11-03       Impact factor: 3.318

5.  Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in Korea.

Authors:  Hyuk Sang Kwon; Kee Ho Song; Jae Myung Yu; Dong Sun Kim; Ho Sang Shon; Kyu Jeung Ahn; Sung Hee Choi; Seung Hyun Ko; Won Kim; Kyoung Hwa Lee; Il Seong Nam-Goong; Tae Sun Park
Journal:  J Obes Metab Syndr       Date:  2021-09-30

6.  Clusters of the Risk Markers and the Pattern of Premature Coronary Heart Disease: An Application of the Latent Class Analysis.

Authors:  Leila Jahangiry; Mahdieh Abbasalizad Farhangi; Mahdi Najafi; Parvin Sarbakhsh
Journal:  Front Cardiovasc Med       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.